On which evidence can we rely when prescribing off-label methotrexate in dermatological practice? – a systematic review with GRADE approach
Astrid M. van Huizen(GGD Amsterdam), Phyllis I. Spuls, R.J. Borgonjen(Valley Hospital), F.M. Vermeulen(Amsterdam University Medical Centers), Cathelijne M. J. M. Bik(Danish College of General Practitioners), Saskia A. T. Karsch(Utrecht University), Rosanna A. Kuin(Amsterdam Neuroscience), Louise A. A. Gerbens(Amsterdam UMC Location University of Amsterdam)
Cited by 0
Related Papers
Definition of treatment goals for moderate to severe psoriasis: a European consensus
|Archives of Dermatological Research|2010|892
Vitiligo-Like Depigmentation in Patients With Stage III-IV Melanoma Receiving Immunotherapy and Its Association With Survival: A Systematic Review and Meta-Analysis
|Journal of Clinical Oncology|2015|619
European guideline (EuroGuiDerm) on atopic eczema: part I – systemic therapy
|Journal of the European Academy of Dermatology and Venereology|2022|419
Increasing Comorbidities Suggest that Atopic Dermatitis Is a Systemic Disorder
|Journal of Investigative Dermatology|2016|377
European guideline (<scp>EuroGuiDerm</scp>) on atopic eczema – part <scp>II</scp>: non‐systemic treatments and treatment recommendations for special <scp>AE</scp> patient populations
|Journal of the European Academy of Dermatology and Venereology|2022|271